健康元

Group Introduction
[Its Dual-Listed Companies] Joincare Pharmaceutical Group (Stock Code: 600380) Livzon Pharmaceutical Group (Stock Code: 000513 Hong Kong Stock Code: 01513)
img
Your location:
Homepage
/
/
/
Shanghai Fangyu Health Pharmaceutical Technology Co., Ltd.

Shanghai Fangyu Health Pharmaceutical Technology Co., Ltd.

  • Time of issue:2020-06-05 15:27
Views:

(Summary description) Shanghai Fangyu Health Pharmaceutical Technology Co., Ltd. was established in September 2013 and is located in Shanghai Zhangjiang High-tech Park. It is the drug R&D center of Joincare Pharmaceutical Group Co., Ltd. in Shanghai. In July 2015, Shanghai Fangyu Health Medical Technology Co., Ltd., with the support of the group, and Guangzhou Institute of Respiratory Diseases led by Academician Zhong Nanshan established a joint venture Guangzhou Healthyuan Respiratory Medicine Engineering Technology Co., Ltd. Shanghai Fangyu Health Medicine Technology Co., Ltd. has an excellent R&D team composed of multi-level scientific and technical personnel including doctors, masters and undergraduates, equipped with more than 140 special equipment, with a total value of more than 20 million yuan, including those adopted by the US and European Pharmacopoeia Evaluation devices for the effectiveness of various inhalation preparations, breathing simulators for different populations, dynamic laser diffraction particle size analyzers for inhalation preparations, and other professional analytical instruments such as HPLC.               Shanghai Fangyu Health Medical Technology Co., Ltd. focuses on the research and development of therapeutic drugs in the field of major diseases, especially the development of inhaled preparations for the treatment of respiratory diseases; engaged in pre-prescription research, pre-clinical pharmaceutical research and project research and development related to drug research and development, Technical consulting and registration services.        R&D team and project results The company's R&D team has long been committed to research on new drug formulations and their industrialization, involving inhalation administration, oral sustained and controlled release administration, injection administration of poorly soluble or thermally unstable drugs, pre-prescription research and other fields. In the past three years since its establishment, the company has been involved in the research and development of more than 20 projects such as innovative drugs, generic drugs, and drug-device combinations. Currently, 2 projects have been applied for clinical application, and 1 project has obtained clinical approval; 6 projects to be declared; 2 A research and development project of a new class 1 drug was funded by the Shanghai Municipal Science and Technology Commission (project numbers: 15431903800 and 16431902500); and a research and development project of an inhalation preparation was funded by the Pudong Science and Technology Commission (project number: PKF2015-CO4). In 2014, the company was approved by the Shanghai Municipal Science and Technology Commission to prepare for the establishment of the "Shanghai Respiratory System Drug Delivery Professional Technical Service Platform, Project Number: 14DZ2293300", and cooperated with the Shanghai Food and Drug Packaging Material Testing Institute to jointly build the "Shanghai Drug Compatibility" Research on the professional technical service platform, project number: 14DZ2293500".       Shanghai Respiratory System Drug Delivery Professional Technical Service Platform Taking the opportunity of the construction of the "Shanghai Respiratory System Drug Delivery Professional Technical Service Platform", Shanghai Fangyu Health Medical Technology Co., Ltd. established a research service platform for respiratory system drug research, evaluation, and engineering development, which is specialized in the development of respiratory system drugs. Research on key engineering technologies for development and industrialization, by breaking through the bottleneck of variety design and localization, accelerating the transformation of technological achievements and upgrading of industrial technology, and providing CRO services for preparation research and related technical consulting for domestic and foreign pharmaceutical companies and research institutions.     Third-party testing services Combined with the research and development of respiratory drug delivery systems, the company features related testing and quality evaluation of inhaled preparations, actively preparing to build a third-party medical testing service platform, and engaging in quality research and testing related to drug development. The application for accreditation of testing laboratories (CNAS) has been submitted to the China National Certification and Accreditation Administration. Shanghai Fangyu Health Pharmaceutical Technology Co., Ltd. sincerely welcomes domestic and foreign pharmaceutical companies, universities and scientific research institutions to come to cooperate and exchange. Contact information: Building 1, No.899 Zuchong Road, Pudong New Area, Shanghai Contact: Mr. Wen Contact number: 021-58368016 Fax: 021-58368002

Shanghai Fangyu Health Pharmaceutical Technology Co., Ltd.

(Summary description)

Shanghai Fangyu Health Pharmaceutical Technology Co., Ltd. was established in September 2013 and is located in Shanghai Zhangjiang High-tech Park. It is the drug R&D center of Joincare Pharmaceutical Group Co., Ltd. in Shanghai. In July 2015, Shanghai Fangyu Health Medical Technology Co., Ltd., with the support of the group, and Guangzhou Institute of Respiratory Diseases led by Academician Zhong Nanshan established a joint venture Guangzhou Healthyuan Respiratory Medicine Engineering Technology Co., Ltd.

Shanghai Fangyu Health Medicine Technology Co., Ltd. has an excellent R&D team composed of multi-level scientific and technical personnel including doctors, masters and undergraduates, equipped with more than 140 special equipment, with a total value of more than 20 million yuan, including those adopted by the US and European Pharmacopoeia Evaluation devices for the effectiveness of various inhalation preparations, breathing simulators for different populations, dynamic laser diffraction particle size analyzers for inhalation preparations, and other professional analytical instruments such as HPLC.

 

         

 

Shanghai Fangyu Health Medical Technology Co., Ltd. focuses on the research and development of therapeutic drugs in the field of major diseases, especially the development of inhaled preparations for the treatment of respiratory diseases; engaged in pre-prescription research, pre-clinical pharmaceutical research and project research and development related to drug research and development, Technical consulting and registration services.

 



 

   R&D team and project results

The company's R&D team has long been committed to research on new drug formulations and their industrialization, involving inhalation administration, oral sustained and controlled release administration, injection administration of poorly soluble or thermally unstable drugs, pre-prescription research and other fields.

In the past three years since its establishment, the company has been involved in the research and development of more than 20 projects such as innovative drugs, generic drugs, and drug-device combinations. Currently, 2 projects have been applied for clinical application, and 1 project has obtained clinical approval; 6 projects to be declared; 2 A research and development project of a new class 1 drug was funded by the Shanghai Municipal Science and Technology Commission (project numbers: 15431903800 and 16431902500); and a research and development project of an inhalation preparation was funded by the Pudong Science and Technology Commission (project number: PKF2015-CO4). In 2014, the company was approved by the Shanghai Municipal Science and Technology Commission to prepare for the establishment of the "Shanghai Respiratory System Drug Delivery Professional Technical Service Platform, Project Number: 14DZ2293300", and cooperated with the Shanghai Food and Drug Packaging Material Testing Institute to jointly build the "Shanghai Drug Compatibility" Research on the professional technical service platform, project number: 14DZ2293500".

 

    Shanghai Respiratory System Drug Delivery Professional Technical Service Platform

Taking the opportunity of the construction of the "Shanghai Respiratory System Drug Delivery Professional Technical Service Platform", Shanghai Fangyu Health Medical Technology Co., Ltd. established a research service platform for respiratory system drug research, evaluation, and engineering development, which is specialized in the development of respiratory system drugs. Research on key engineering technologies for development and industrialization, by breaking through the bottleneck of variety design and localization, accelerating the transformation of technological achievements and upgrading of industrial technology, and providing CRO services for preparation research and related technical consulting for domestic and foreign pharmaceutical companies and research institutions.



    Third-party testing services

Combined with the research and development of respiratory drug delivery systems, the company features related testing and quality evaluation of inhaled preparations, actively preparing to build a third-party medical testing service platform, and engaging in quality research and testing related to drug development. The application for accreditation of testing laboratories (CNAS) has been submitted to the China National Certification and Accreditation Administration.

Shanghai Fangyu Health Pharmaceutical Technology Co., Ltd. sincerely welcomes domestic and foreign pharmaceutical companies, universities and scientific research institutions to come to cooperate and exchange.




Contact information:

Building 1, No.899 Zuchong Road, Pudong New Area, Shanghai

Contact: Mr. Wen

Contact number: 021-58368016

Fax: 021-58368002


  • Time of issue:2020-06-05 15:27
  • Views:
Information

Shanghai Fangyu Health Pharmaceutical Technology Co., Ltd. was established in September 2013 and is located in Shanghai Zhangjiang High-tech Park. It is the drug R&D center of Joincare Pharmaceutical Group Co., Ltd. in Shanghai. In July 2015, Shanghai Fangyu Health Medical Technology Co., Ltd., with the support of the group, and Guangzhou Institute of Respiratory Diseases led by Academician Zhong Nanshan established a joint venture Guangzhou Healthyuan Respiratory Medicine Engineering Technology Co., Ltd.

Shanghai Fangyu Health Medicine Technology Co., Ltd. has an excellent R&D team composed of multi-level scientific and technical personnel including doctors, masters and undergraduates, equipped with more than 140 special equipment, with a total value of more than 20 million yuan, including those adopted by the US and European Pharmacopoeia Evaluation devices for the effectiveness of various inhalation preparations, breathing simulators for different populations, dynamic laser diffraction particle size analyzers for inhalation preparations, and other professional analytical instruments such as HPLC.

 

1   2   3   4
 

Shanghai Fangyu Health Medical Technology Co., Ltd. focuses on the research and development of therapeutic drugs in the field of major diseases, especially the development of inhaled preparations for the treatment of respiratory diseases; engaged in pre-prescription research, pre-clinical pharmaceutical research and project research and development related to drug research and development, Technical consulting and registration services.

 

5

 

   R&D team and project results

The company's R&D team has long been committed to research on new drug formulations and their industrialization, involving inhalation administration, oral sustained and controlled release administration, injection administration of poorly soluble or thermally unstable drugs, pre-prescription research and other fields.

In the past three years since its establishment, the company has been involved in the research and development of more than 20 projects such as innovative drugs, generic drugs, and drug-device combinations. Currently, 2 projects have been applied for clinical application, and 1 project has obtained clinical approval; 6 projects to be declared; 2 A research and development project of a new class 1 drug was funded by the Shanghai Municipal Science and Technology Commission (project numbers: 15431903800 and 16431902500); and a research and development project of an inhalation preparation was funded by the Pudong Science and Technology Commission (project number: PKF2015-CO4). In 2014, the company was approved by the Shanghai Municipal Science and Technology Commission to prepare for the establishment of the "Shanghai Respiratory System Drug Delivery Professional Technical Service Platform, Project Number: 14DZ2293300", and cooperated with the Shanghai Food and Drug Packaging Material Testing Institute to jointly build the "Shanghai Drug Compatibility" Research on the professional technical service platform, project number: 14DZ2293500".

 

    Shanghai Respiratory System Drug Delivery Professional Technical Service Platform

Taking the opportunity of the construction of the "Shanghai Respiratory System Drug Delivery Professional Technical Service Platform", Shanghai Fangyu Health Medical Technology Co., Ltd. established a research service platform for respiratory system drug research, evaluation, and engineering development, which is specialized in the development of respiratory system drugs. Research on key engineering technologies for development and industrialization, by breaking through the bottleneck of variety design and localization, accelerating the transformation of technological achievements and upgrading of industrial technology, and providing CRO services for preparation research and related technical consulting for domestic and foreign pharmaceutical companies and research institutions.

6

    Third-party testing services

Combined with the research and development of respiratory drug delivery systems, the company features related testing and quality evaluation of inhaled preparations, actively preparing to build a third-party medical testing service platform, and engaging in quality research and testing related to drug development. The application for accreditation of testing laboratories (CNAS) has been submitted to the China National Certification and Accreditation Administration.

Shanghai Fangyu Health Pharmaceutical Technology Co., Ltd. sincerely welcomes domestic and foreign pharmaceutical companies, universities and scientific research institutions to come to cooperate and exchange.

7


Contact information:

Building 1, No.899 Zuchong Road, Pudong New Area, Shanghai

Contact: Mr. Wen

Contact number: 021-58368016

Fax: 021-58368002

Scan the QR code to read on your phone

Quick Navigation

Service Hotline

Service

Hotline

Copyright © Joincare Pharmaceutical Group Industry Co., Ltd. All Rights Reserved.  Powered by:www.300.cn Zhuhai  粤ICP备14024104号